Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference
Craig F McCabe, Shannon E McCabeMcCabe Vision Center, Murfreesboro, TN, USABackground: The aim of this study was to compare patient-perceived relief of ocular itch, nasal symptoms, and eye drop comfort when allergic conjunctivitis was treated with bepotastine besilate 1.5% versus olopatadine hydroch...
Main Authors: | McCabe CF, McCabe SE |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-10-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/comparative-efficacy-of-bepotastine-besilate-15-ophthalmic-solution-ve-a11381 |
Similar Items
-
Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%
by: Bergmann MT, et al.
Published: (2014-08-01) -
Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis
by: Cavet ME, et al.
Published: (2018-03-01) -
Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis
by: Shruti Ayyappanavar, et al.
Published: (2021-01-01) -
Bepotastine besilate: A novel anti-histamine
by: Kiran Godse, et al.
Published: (2017-01-01) -
Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%
by: Jack V Greiner, et al.
Published: (2011-01-01)